c-Kit Mutation and Localization Status as Response Predictors in Mast Cell Tumors in Dogs Treated with Prednisone and Toceranib or Vinblastine.
Kristen M WeishaarE J EhrhartA C AveryJ B CharlesR E ElmslieD M VailC A LondonC A CliffordJ C EickhoffDouglas H ThammPublished in: Journal of veterinary internal medicine (2017)
Neither PFS nor OS was significantly different between treatment groups. As the proportion of dogs with c-kit mutations was not different between treatment groups in this population of dogs, c-kit mutation status did not predict treatment response.
Keyphrases